Aidoc, a provider of artificial intelligence (AI) solutions for medical imaging, announced on Tuesday today a $66 million investment, bringing its total funding to over $140 million.
Follow Israel Hayom on Facebook and Twitter
This Series C round, led by General Catalyst, follows a surge in demand for Aidoc's AI-driven solutions, including the largest clinical deployment of AI in healthcare through its partnership with Radiology Partners.
"This investment comes after significant milestones; expanding our product lines, doubling our FDA clearances and quadrupling our customer base," said Aidoc co-founder and CEO Elad Walach. "We are experiencing a huge expansion, which is also a direct result of C-level executives adopting an AI strategy and integrating our platform as a must-have solution across clinical pathways. It is truly rewarding – and a great responsibility – to be the trusted partner of the most innovative health systems and physician practices across the globe."
"At General Catalyst, we believe in addressing the big challenges in healthcare, and it is clear to us that Aidoc has both a bold vision to use AI to set a new standard of care in medical imaging and a concrete plan to reach that," said Chris Bischoff, Managing Director at General Catalyst.
